The Pennant Group (NASDAQ:PNTG – Get Free Report)‘s stock had its “overweight” rating reaffirmed by investment analysts at Stephens in a note issued to investors on Tuesday, Benzinga reports. They presently have a $23.00 price target on the stock. Stephens’ target price would suggest a potential upside of 7.83% from the company’s previous close.
A number of other equities analysts also recently commented on PNTG. Truist Financial boosted their price objective on The Pennant Group from $16.00 to $21.00 and gave the stock a “hold” rating in a research report on Friday, March 1st. Oppenheimer upped their price target on The Pennant Group from $18.00 to $22.00 and gave the stock an “outperform” rating in a research note on Friday, March 1st.
Check Out Our Latest Research Report on The Pennant Group
The Pennant Group Price Performance
The Pennant Group (NASDAQ:PNTG – Get Free Report) last posted its quarterly earnings data on Wednesday, February 28th. The company reported $0.18 earnings per share for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.01). The company had revenue of $145.95 million for the quarter, compared to analysts’ expectations of $136.79 million. The Pennant Group had a return on equity of 12.78% and a net margin of 2.46%. During the same period in the previous year, the business posted $0.15 EPS. Equities analysts expect that The Pennant Group will post 0.73 earnings per share for the current fiscal year.
Institutional Trading of The Pennant Group
Several hedge funds have recently made changes to their positions in PNTG. AJOVista LLC acquired a new position in shares of The Pennant Group during the fourth quarter valued at approximately $35,000. DekaBank Deutsche Girozentrale purchased a new position in The Pennant Group during the 4th quarter worth approximately $52,000. Allspring Global Investments Holdings LLC raised its stake in The Pennant Group by 21.0% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 5,443 shares of the company’s stock valued at $61,000 after purchasing an additional 944 shares during the period. SG Americas Securities LLC purchased a new stake in shares of The Pennant Group in the fourth quarter valued at $107,000. Finally, Mackenzie Financial Corp purchased a new position in shares of The Pennant Group during the fourth quarter valued at $155,000. Institutional investors own 85.88% of the company’s stock.
The Pennant Group Company Profile
The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.
See Also
- Five stocks we like better than The Pennant Group
- ETF Screener: Uses and Step-by-Step Guide
- Freshpet Surges 10%: Fresh Highs to Come for This Pet Stock
- Consumer Staples Stocks, Explained
- Hims & Hers Health Stock Could Become a Wealth Compounder
- Investing in Travel Stocks Benefits
- 3 Penny Stocks That Insiders Are Buying
Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.